healthcarepolicy

Cigna and Humana Merger Prospects: The Election's Critical Role

2 months ago

As the countdown to the 2024 elections intensifies, analysts suggest that the impending political landscape may significantly influence the potential merger between Cigna Corporation and Humana Inc. According to industry experts, the deal's success could be heavily reliant on the outcome of federal elections, which might determine the regulatory environment for large healthcare mergers.

France Contemplates State Stake in Sanofi’s Asset Sale to CD&R

2 months ago

In a pivotal move that could redefine the landscape of France's healthcare sector, the French government is considering acquiring a stake in a Sanofi subsidiary that is currently set to be sold to the private equity firm Clayton, Dubilier & Rice (CD&R). This potential stake acquisition comes as Sanofi, a leading global biopharmaceutical company, seeks to divest certain assets to focus on its core operations and enhance its strategic initiatives.

Medicare's Future Spending: Obesity Drugs Projected to Cost $35 Billion by 2034

3 months ago

In a significant healthcare development, it has been projected that Medicare will incur expenses exceeding $35 billion for obesity drugs over the next decade. This forecast stems from the growing adoption of weight-loss medications, which have been increasingly recognized for their efficacy in combating obesity.